Clinical Trials
4
Active:1
Completed:2
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Zomagen Biosciences Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06836232
- Locations
- 🇺🇸
Local Site #840005, Rochester, Minnesota, United States
🇺🇸Local Site #840004, Richmond, Virginia, United States
🇺🇸Local Site #840012, Tucson, Arizona, United States
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
Phase 2
Active, not recruiting
- Conditions
- Obesity
- Interventions
- Drug: VTX3232 Dose ADrug: Placebo in combination with semaglutideDrug: PlaceboDrug: VTX3232 Dose A in combination with semaglutide
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Zomagen Biosciences Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT06771115
- Locations
- 🇺🇸
840005, Birmingham, Alabama, United States
🇺🇸840003, Lake Forest, California, United States
🇺🇸840011, Long Beach, California, United States
Phase 2a Study of VTX3232 in Parkinson's Disease
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Zomagen Biosciences Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT06556173
- Locations
- 🇺🇸
Local Site #840001, New Haven, Connecticut, United States
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Zomagen Biosciences Ltd.
- Target Recruit Count
- 7
- Registration Number
- NCT05812781
- Locations
- 🇺🇸
Local Site # 222, San Diego, California, United States
🇺🇸Local Site # 223, Columbus, Georgia, United States
News
No news found